Advanced search
Publication Cover
Infectious Diseases Volume 56, 2024 - Issue 1
Submit an article Journal homepage
157
Views
0
CrossRef citations to date
0
Altmetric
Comment

Monoclonal antibodies for the prevention of Plasmodium falciparum malaria: a multi-target approach?

Temi LampejoDepartment of Infection Sciences, King’s College Hospital, London, UKCorrespondence[email protected]
Pages 73-77 | Received 19 Oct 2023, Accepted 19 Oct 2023, Published online: 03 Nov 2023

References

  • World Health Organisation. World malaria report 2022. https://www.who.int/publications/i/item/9789240064898.
  • World Health Organisation. World Malaria Report 2021. 2021; published online Dec 6. https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2021.
  • Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in africa: final results of a phase 3, individually randomised, controlled trial. The Lancet. 2015;386:31–45.
  • Björkman A, Benn CS, Aaby P, et al. RTS,S/AS01 malaria vaccine—proven safe and effective? Lancet Infect Dis. 2023;23(8):e318–e322. doi:10.1016/S1473-3099(23)00126-3.
  • Datoo MS, Natama HM, Somé A, et al. Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years’ follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial. Lancet Infect Dis. 2022;22(12):1728–1736. doi:10.1016/S1473-3099(22)00442-X.
  • Julien J-P, Wardemann H. Antibodies against Plasmodium falciparum malaria at the molecular level. Nat Rev Immunol. 2019;19(12):761–775. doi:10.1038/s41577-019-0209-5.
  • Cohen S, McGREGOR IA, Carrington S. Gamma-Globulin and acquired immunity to human Malaria. Nature. 1961;192(4804):733–737. doi:10.1038/192733a0.
  • McGregor IA, Rowe DS, Wilson ME, et al. Plasma immunoglobulin concentrations in an african (gambian) community in relation to season, malaria and other infections and pregnancy. Clin Exp Immunol. 1970;7:51–74.
  • Aleshnick M, Florez-Cuadros M, Martinson T, et al. Monoclonal antibodies for malaria prevention. Mol Ther. 2022;30(5):1810–1821. doi:10.1016/j.ymthe.2022.04.001.
  • van der Boor SC, Smit MJ, van Beek SW, et al. Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-Centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults. Lancet Infect Dis. 2022;22(11):1596–1605. doi:10.1016/S1473-3099(22)00428-5.
  • Singh SK, Thrane S, Chourasia BK, et al. Pfs230 and Pfs48/45 fusion proteins elicit strong transmission-blocking antibody responses against Plasmodium falciparum. Front Immunol. 2019;10:1256. doi:10.3389/fimmu.2019.01256.
  • Gaudinski MR, Berkowitz NM, Idris AH, et al. A monoclonal antibody for malaria prevention. N Engl J Med. 2021;385(9):803–814. doi:10.1056/NEJMoa2034031.
  • Wu RL, Idris AH, Berkowitz NM, et al. Low-Dose subcutaneous or intravenous monoclonal antibody to prevent malaria. N Engl J Med. 2022;387(5):397–407. doi:10.1056/NEJMoa2203067.
  • Wang LT, Pereira LS, Flores-Garcia Y, et al. A potent anti-malarial human monoclonal antibody targets circumsporozoite protein minor repeats and neutralizes sporozoites in the liver. Immunity. 2020;53(4):733–744.e8. doi:10.1016/j.immuni.2020.08.014.
  • Focosi D, McConnell S, Casadevall A, et al. Monoclonal antibody therapies against SARS-CoV-2. Lancet Infect Dis. 2022;22(11):e311–26–e326. doi:10.1016/S1473-3099(22)00311-5.
  • Stone WJR, Campo JJ, Ouédraogo AL, et al. Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity. Nat Commun. 2018;9(1):558. doi:10.1038/s41467-017-02646-2.
  • Stone WJR, Dantzler KW, Nilsson SK, et al. Naturally acquired immunity to sexual stage P. falciparum parasites. Parasitology. 2016;143(2):187–198. doi:10.1017/S0031182015001341.
  • Andolina C, Rek JC, Briggs J, et al. Sources of persistent malaria transmission in a setting with effective malaria control in Eastern Uganda: a longitudinal, observational cohort study. Lancet Infect Dis. 2021;21(11):1568–1578. doi:10.1016/S1473-3099(21)00072-4.
  • Alanine DGW, Quinkert D, Kumarasingha R, et al. Human antibodies that slow erythrocyte invasion potentiate Malaria-Neutralizing antibodies. Cell. 2019;178(1):216–228.e21. doi:10.1016/j.cell.2019.05.025.
  • Weiss GE, Ragotte RJ, Quinkert D, et al. The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: blocking invasion and inactivating extracellular merozoites. PLoS Pathog. 2023;19(9):e1011182. doi:10.1371/journal.ppat.1011182.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.